INTRODUCTION
The extracellular matrix (ECM) is an intricate assembly of proteins tlat includes collagen, laminin, and fibronectin, among others (1). Cells interact with these proteins and with each other via specific receptors located on their surface. A major class of these receptors is the integrins, each of which is composed of two distinct a and p transmembrane glycoprotein subunits that are noncovalently linked (2). The integrins are classified into families of receptors. For example, the integrin family, also called very late after activation antigens (VLA), is implicated in cell adhesion to the ECM (2); a member of this family, VLA4, is also involved in cell-cell interactions (3). The integrins bind to specific recognition sites on ECM proteins. One of these sites, which is present on fibronectin (FN), is composed of an Arg-Gly-Asp-Ser (RGDS) motif (4). Synthetic peptides containing RGDS have been found to promote cell adhesion when immobilized on suitable substrates and to inhibit cell adhesion to tissue culture dishes precoated with FN (5).
Macrophages adhere to, spread on, and engulf foreign particles, including microorganisms; adherence and spreading on foreign substrates (including tissue culture dishes) are considered to be hallmarks of macrophages. A number of ECM proteins have been shown to enhance the maturation of blood monocytes into macrophages (6-8). It is thus conceivable that adhesion molecules not only define macrophage characteristics but also participate in the process that leads to macrophage differentiation. We report here the role specific adhesion molecules, FN in particular, play in macrophage differentiation of human leukemia cells and monocytes.
MATERIALS AND METHODS
Reagents. Isotypic controls (IgG,, IgG, and IgG,d, murine monoclonal antibodies (MAbs) to human fibronectin (FN-15, IgG,) , an a-naphthyl acetate esterase assay kit, RGDS and GPRP peptides, all-trans-retinoic acid @A), and Ficoll-Hypaque were purchased from Sigma Chemical Co. (St. Louis, MO) . Anti-VLA MAb, an antibody to the human p1 chain of VLA, CD, (K20, IgG,); and human a, chain integrin, CD,g (SAM1,
were purchased from Immunotech (Westbrook, ME). Indocmymine-conjugated anti-murine goat immunoglobulin (CY3m) was purchased from Jackson Immunoresearch Lab, Inc., (West Grove, PA), and anti-human integrin oly& complex, CDsl/CD,, MAb (23CG, IgG1) from Pharmingen (San Diego, CA). Anti-human p4 integrin was kindly provided by Dr. S. Kennel (Oak Ridge National Laboratory). M-CSF was purchased from Biosource International (Camarilo, CA), and plates precoated with either mouse laminin, collagen type I, or collagen type N from Becton Dickinson (Bedford, MA).
Cells and Cell Culture. The human myeloid HL-60 leukemia cell line was originally obtained from R.C. Gallo (National Cancer Institute). The HL-525 and HL-534 cells (9, lo), as well as the HL-525 cells transfected with either PKC& cDNA (HL-525/pI-C and HL-525/pI-F) or control vector (HL-525/neo), were established in our laboratory (1 1). Monocytes were obtained from heparinized whole human venous blood and separated by Ficoll-Hypaque density gradient (1.077 dml) centrifugation as previously described (12). The cells were incubated in tissue culture plates with RPMI 1640 medium supplemented with 15% heat-inactivated fetal calf serum (Intergen Co., NY), 100 pg/ml penicillin-streptomycin, and 2 mM L-glutamine (Life Technologies, Inc., Grand Island, NY) in a humidified atmosphere containing 8% CO, at 37OC.
Differentiation markers.
To determine the percentage of adherent and spread cells, we inoculated (2.5-5) x 10s cells in 0.5 ml of medium into each well of a 24-well tissue culture plate in the presence or absence of PMA or M-CSF. For some experiments, we precoated the surface of the wells with either FN or bovine Serum albumin (BSA) by overnight incubation at room temperature with 0.5 ml solution containing 20 pg protein/ml. The nonspecific sites were blocked with 1% BSA in PBS for 30 min. The wells were then washed with 3 mM MnC12, inoculated with the cells, and incubated for different time intervals. The percentage of cell attachment and cell spreading was deterrnined as previously described (13). The fraction of attached cells was up to 20% higher than the percentage of attached cells with apparent spreading. Nonspecific esterase activity was determined by using the a-naphthyl acetate esterase assay kit as described by the manufacturer. Phagocytosis was determined as described previously Immunofluorescence. The immunostaining procedures were carried out at 4°C using either 96-microwell plates or tissue culture chamber slides (Nunc, Inc., Naperville, L). The cells were washed twice with PBSA (PBS containing 1% BSA and 0.1% NaN,) and were incubated for 45 min with the appropriate primary MAb under saturating conditions. The cells were then washed again twice with PBSA and incubated for an additional 45 min with the secondary antibody CY3TM. After an additional wash with PBSA, the slides were mounted with phosphate-buffered Gelvatolm (Becton Dickinson, Sunnyvale, CA). Fluorescence was examined using a MAC Digital Confocal microscope.
RT-PCR Analysis. RNA was purified by centrifugation through a CsCl cushion as previously described (14). cDNA was synthesized from total cellular RNA using Superscriptm II reverse transcriptase (GibcoBRL) and the conditions recommended by the supplier. The reverse transcription (RT) reaction used 2 pg of total RNA and either 100 ng of oligo(dT) primer or 2 pmol of a gene-specific primer. Polymerase chain reaction (PCR) amplification used the Tfr polymerase (Stratagene) and conditions recommended by the supplier. The FN template primers, FlF/F2R (nucleotides [nt] 3945-3966 and 4325-4346; 396-bp product) and F5F/F6R (nt 398 1 4 0 0 1 ; 746-bp product) were derived'fiom the human sequence (Genbank accession number X02761). The Combination of primer F1F and F6R resulted in a 782-bp PCR product. The template primers for human glyceraldehyde-3-phosphate dehydrogenase (GAPDH), GlF/G2R (nt 713-734; 715-bp product), were derived from the human sequence (Genbank accession number X01677). One set of cycle parameters were used for all primers (denaturation at 94"C, 50 seconds; annealing at 63"C, 1 min; extension at 73OC, 1 min) with the total number of cycles (25-40) tailored to the specific primer pair. For all reactions, various amounts of the reverse transcriptase reaction were used to insure correspondence between the amount of amplified product and the input cDNA. For the FN amplification reactions, at least three independent primers pairs were used for each set of reverse transcriptase products to validate the amplification pattern. Because integrins belonging to other families may also be involved in macrophage differentiatien, we examined the immunostaining pattern of q P 3 integrin, which also binds FN through its RGDS motif (2, 17). For comparison, we included MAb to the p4 integrin which binds to laminin but not to FN (18) . Untreated HL-60 cells exhibited little or no immunostaining with the cq& MAb. After treatment for 2 d with PMA, 50% of the cells reacted with the MAb; however, the immunofluorescence was less intense than that observed in PMA-treated cells reacting with the VLA MAb. In contrast, untreated HL-60 cells showed reactivity with the p4
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MAb, but the reactivity decreased markedly after PMA treatment.
Freshly isolated peripheral blood monocytes exhibited weak immunostaining for VLA and FN.
After two days in culture, the cells displayed some immunostaining for these antigens (Fig. 2) .
Treatment of the isolated monocytes with either 3 nM PMA or 240 U/ml M-CSF for 2 d caused a marked increase in the intensity of the immunostaining, which was scattered throughout the surface of the cells. The treated cells also exhibited a typical macrophage cell spreading ( Fig. 2) -A noteworthy observation was the abundance of speckled FN immunostaining in the intercellular spaces of the dishes containing activated monocytes or HL-60 macrophages, but not in those containing control cells (Figs. 1 and 2) . Limited, scattered intercellular VLA immunostaining was also observed in the vicinity of the adherent macrophages ( Figs. 1 and 2) . Little or no immunostaining with the isotypic control antibodies was observed in untreated cells.
Differentiated monocytes or HL-60 cells yielded weak immunostaining with these antibodies, which we regarded as background.
To provide evidence that protein kinase C (PKC) is not only involved in PMA-and M-CSFinduced macrophage differentiation (11, 19) Inhibition of PMA-induced macrophage differentiation in HL-60 cells. We tested the RGDS peptide and MAbs to FN and specific integrins for the ability to alter macrophage differentiation in HL-60 cells. Our results indicated that the anti-FN, anti-VLA and anti-a5 MAbs and the RGDS peptide attenuated the manifestation of PMA-evoked macrophage markers such as cell adherence and spreading, staining for non-specific esterase activity, and phagocytosis (Table 1) .
Moreover, the anti-FN, anti-VLA, and anti+ antibodies and the exogenous RGDS peptide inhibited the PMA-evoked reduction in the number of cells (Table 1) , which to a large degree is due to apoptosis (22). We also tested the MAbs to the q p 3 and p4 integrins for their ability I t to inhibit cell adherence and spreading. The a & MAb caused a reduction of 25-30% in adherence and spreading and in phagocytosis. In contrast, the P4 MAb failed to affect these markers in the PMA-treated cells. Control antibodies and the control peptide GPRI? had no effect on the expression of the PMA-induced markers or on the reduction in the number of cells uable 1). The MAbs or the peptides also had little or no effect on the replication or expression of maturation markers in control HL-60 cells (Table 1) . (Fig. 4) . These products were either absent or detected at low levels in untreated and PMA-treated HL-525 cells (Fig. 4) .
Restoration of FN
In contrast, PMA-induced FN-specific amplification praducts were detected in HL-525 cells transfected with PKCP cDNA or pretreated with RA, but not in HL-525 cells transfected with the control vector or treated with RA alone (Fig. 4) . (Table 4) .
Inhibition of macrophage differentiation in monocytes by
These two MAbs were each also able to reduce the fraction of cells exhibiting phagocytosis in both the untreated and the treated monocytes (Table 4) .
DISCUSSION
We propose that induction and interaction of cellular receptors such as integrins with specific ECM proteins (which are secreted by the cells and deposited on foreign substrates) are steps in a process that brings about macrophage differentiation in appropriate progenitor cells. We focused our attention on the PI integrin family of receptors and fibronectin, because these adhesion proteins have been reported to be present in blood macrophages (29,30). We used HL-60 cells and peripheral blood monocytes for these studies because they can acquire a macrophage phenotype upon treatment with specific stimuli (11, 27, 28, 31).
In our initial experiments, we determined the cell surface level of VLA and FN antigens in HL- Proof that increased levels of FN and VLA are intimately involved in the induction process itself came from our two experimental approaches. In one approach, we tested the ability of anti-VLA, anti-FN MAb, and the RGDS peptide to block macrophage differentiation in HL-60 cells and monocytes. We assumed that these molecules would prevent the interaction of VLA with the deposited FN, with its RGDS motif in particular. If this interaction is critical for macrophage differentiation, then the presence of either antibody or the peptide should inhibit such differentiation. Our studies indicate that indeed both the anti-VLA and anti-FN MAbs were able to attenuate macrophage differentiation in monocyte and HL-60 cells. Because other integrin families might also be involved in the interaction with FN (2), we included a MAb to qp3, an integrin that is present in cultured human macrophages (35) and that also binds FN through its cells. Cells were either incubated in the absence or the presence of 3 nM PMA and were then reacted with the anti-VLA or anti-FN MAbs. .
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